Partnering with Celerion means working with one of the most experienced CROs in the world.
With over 40 years of experience, more than 750 beds in North America and Europe, Celerion offers the largest global Phase I and IIa clinical operations networks in the industry.
Celerion is a market leader in Early Cardiac Services, having completed over 40 TQT and more than 100 robust QT studies. In 2010 Celerion launched the first Hybrid Phase I/ECG Core lab in the market. Integrating the ECG functions within Celerion’s Phase I clinic network, minimizing traditional ECG overhead and providing more automation, has enabled fast access to data and cost-effective solutions that deliver high-quality data for the execution of thorough QT studies and ECG assessment in SAD and MAD programs.
In 2011 Celerion launched the addition of a USP Clean Room to enable efficient execution of microtracer and microdosing studies. The USP Clean Room also allows for all types of complex extemporaneous compounding for low, medium and high risk investigational compounds. Clients benefit by accessing quality data earlier in drug development process.
Celerion's clinical site in Lincoln, Nebraska is licensed to conduct studies with radiolabeled compounds. In the last 10 years, the clinical team in Lincoln, Nebraska has conducted more than 40 radiolabeled clinical trials, dosing nearly 300 participants, successfully recruiting healthy normal males, females and elderly subjects.
The company's breadth of capabilities coupled with purpose built facilities (co-located Pharmacy, clinical laboratories and flexible conduct areas) ensure the quality data is delivered on time.
Phase I and IIa Services:
- ACLS Certified Nursing Staff
- Analytical laboratory
- Dedicated IRB
- Electronic Case Report Form (CRF)
- Electronic data capture
- On-site clinical laboratory
- On-site pharmacy with licensed pharmacists
- Oracle / SAS programming
- Project management
- Quality control
- Quality assurance
- Recruitment / outreach
Global Clinical Research offers clinical conduct with centralized 24-hour scheduling, rapid recruitment and thought leadership that includes broad therapeutic area expertise.